AAAAAA
Results: 1-25/72
Authors:
Hartmann, JT
Fossa, SD
Nichols, CR
Droz, JP
Horwich, A
Gerl, A
Beyer, J
Pont, J
Fizazi, K
Hecker, H
Kanz, L
Einhorn, L
Bokemeyer, C
Citation: Jt. Hartmann et al., Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors, J NAT CANC, 93(22), 2001, pp. 1733-1738
Authors:
Dittmann, H
Sokler, M
Kollmannsberger, C
Dohmen, BM
Baumann, C
Kopp, A
Bares, R
Claussen, CD
Kanz, L
Bokemeyer, C
Citation: H. Dittmann et al., Comparison of (18)FDG-PET with CT scans in the evaluation of patients withresidual and recurrent Hodgkin's lymphoma, ONCOL REP, 8(6), 2001, pp. 1393-1399
Authors:
Kuczyk, MA
Bokemeyer, C
Hartmann, J
Schubach, J
Walter, C
Machtens, S
Knuchel, R
Kollmannsberger, C
Jonas, U
Serth, J
Citation: Ma. Kuczyk et al., Predictive value of altered p27(Kip1) and p21(WAF/Cip1) protein expressionfor the clinical prognosis of patients with localized prostate cancer, ONCOL REP, 8(6), 2001, pp. 1401-1407
Authors:
Kolb, G
Bokemeyer, C
Citation: G. Kolb et C. Bokemeyer, The old cancer patient, Z GERON GER, 34(4), 2001, pp. 260-262
Authors:
Kohne, CH
Grothey, A
Bokemeyer, C
Bontke, N
Aapro, M
Citation: Ch. Kohne et al., Chemotherapy in elderly patients with colorectal cancer, ANN ONCOL, 12(4), 2001, pp. 435-442
Authors:
Hartmann, JT
Einhorn, L
Nichols, CR
Droz, JP
Horwich, A
Gerl, A
Fossa, SD
Beyer, J
Pont, J
Schmoll, HJ
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results of an international multicenter analysis, J CL ONCOL, 19(6), 2001, pp. 1641-1648
Authors:
De Santis, M
Bokemeyer, C
Becherer, A
Stoiber, F
Oechsle, K
Kletter, K
Dohmen, BM
Dittrich, C
Pont, J
Citation: M. De Santis et al., Predictive impact of 2-(18)fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma, J CL ONCOL, 19(17), 2001, pp. 3740-3744
Authors:
Bokemeyer, C
Gillis, AJM
Pompe, K
Mayer, F
Metzner, B
Schleucher, N
Schleicher, J
Pflugrad-Jauch, G
Oosterhuis, JW
Kanz, L
Looijenga, LHJ
Citation: C. Bokemeyer et al., Clinical impact of germ cell tumor cells in apheresis products of patientsreceiving high-dose chemotherapy, J CL ONCOL, 19(12), 2001, pp. 3029-3036
Authors:
Fizazi, K
Tjulandin, S
Salvioni, R
Germa-Lluch, JR
Bouzy, J
Ragan, D
Bokemeyer, C
Gerl, A
Flechon, A
de Bono, JS
Stenning, S
Horwich, A
Pont, J
Albers, P
De Giorgi, U
Bower, M
Bulanov, A
Pizzocaro, G
Aparicio, J
Nichols, CR
Theodore, C
Hartmann, JT
Schmoll, HJ
Kaye, SB
Culine, S
Droz, JP
Mahe, C
Citation: K. Fizazi et al., Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy-results from an international study group, J CL ONCOL, 19(10), 2001, pp. 2647-2657
Authors:
Rick, O
Bokemeyer, C
Beyer, J
Hartmann, JT
Schwella, N
Kingreen, D
Neureither, S
Metzner, B
Casper, J
Wandt, H
Hartmann, F
Schmoll, HJ
Derigs, G
Gerl, A
Berdel, WE
Kanz, L
Siegert, W
Citation: O. Rick et al., Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer, J CL ONCOL, 19(1), 2001, pp. 81-88
Authors:
Bokemeyer, C
Citation: C. Bokemeyer, Chemotherapy for urogenital malignancies, WORLD J URO, 19(2), 2001, pp. 75-75
Authors:
Beyer, J
Rick, O
Siegert, W
Bokemeyer, C
Citation: J. Beyer et al., Salvage chemotherapy in relapsed germ cell tumors, WORLD J URO, 19(2), 2001, pp. 90-93
Authors:
Kollmannsberger, C
Mayer, F
Kuczyk, M
Kanz, L
Bokemeyer, C
Citation: C. Kollmannsberger et al., Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy, WORLD J URO, 19(2), 2001, pp. 120-125
Authors:
Bokemeyer, C
Kolb, G
Citation: C. Bokemeyer et G. Kolb, The situation of elderly cancer patients, ONKOLOGIE, 24(4), 2001, pp. 324-325
Authors:
Genvresse, I
Wedding, U
Bokemeyer, C
Spath-Schwalbe, E
Citation: I. Genvresse et al., Treatment of multiple myeloma in the elderly: Consensus of the cooperativegroup of geriatric oncology of the DGHO and DGG, ONKOLOGIE, 24(4), 2001, pp. 386-390
Authors:
Buntzel, J
Bokemeyer, C
Wagner, W
Citation: J. Buntzel et al., Recommendations of the Working Group 'Supportive Massnahmen in der Onkologie' concerning the clinical use of cytoprotectives, ONKOLOGIE, 24(1), 2001, pp. 81-86
Authors:
Honecker, F
Wedding, U
Kolb, G
Bokemeyer, C
Citation: F. Honecker et al., Chemotherapy in colorectal cancer - Which therapy is justified in elderly patients?, ONKOLOGIE, 24(1), 2001, pp. 87-94
Authors:
Machtens, S
Serth, J
Bokemeyer, C
Bathke, W
Minssen, A
Kollmannsberger, C
Hartmann, J
Knuchel, R
Kondo, M
Jonas, U
Kuczyk, M
Citation: S. Machtens et al., Expression of the p53 and maspin protein in primary prostate cancer: Correlation with clinical features, INT J CANC, 95(5), 2001, pp. 337-342
Authors:
Bokemeyer, C
Droz, JP
Horwich, A
Gerl, A
Fossa, SD
Beyer, J
Pont, J
Schmoll, HJ
Kanz, L
Einhorn, L
Nichols, CR
Hartmann, JT
Citation: C. Bokemeyer et al., Extragonadal seminoma - An international multicenter analysis of prognostic factors and long term treatment outcome, CANCER, 91(7), 2001, pp. 1394-1401
Authors:
Hartmann, JT
von Vangerow, A
Fels, LM
Knop, S
Stolte, H
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplanation, BR J CANC, 84(3), 2001, pp. 313-320
Authors:
Hartmann, JT
Nichols, CR
Droz, JP
Horwich, A
Gerl, A
Fossa, SD
Beyer, J
Pont, J
Fizazi, K
Einhorn, L
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors, J NAT CANC, 92(1), 2000, pp. 54-61
Authors:
Kollmannsberger, C
Gerl, A
Schleucher, N
Beyer, J
Kuczyk, M
Rick, O
Gasper, J
Sosada, M
Rie, C
Kanz, L
Bokemeyer, C
Citation: C. Kollmannsberger et al., Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer, ANTI-CANC D, 11(7), 2000, pp. 535-539
Authors:
Hartmann, JT
Knop, S
Fels, LM
van Vangerow, A
Stolte, H
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors, ANTI-CANC D, 11(1), 2000, pp. 1-6
Authors:
Bethge, W
Guggenberger, D
Bamberg, M
Kanz, L
Bokemeyer, C
Citation: W. Bethge et al., Thyroid toxicity of treatment for Hodgkin's disease, ANN HEMATOL, 79(3), 2000, pp. 114-118
Authors:
Kollmannsberger, C
Nichols, C
Meisner, C
Mayer, F
Kanz, L
Bokemeyer, C
Citation: C. Kollmannsberger et al., Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: An explorative analysis using cart modeling, ANN ONCOL, 11(9), 2000, pp. 1115-1120